Scinai Immunotherapeutics (SCNI) Non Operating Income (2018 - 2023)

Scinai Immunotherapeutics has disclosed Non Operating Income across 6 years of filings, most recently posting $6.9 million for Q4 2023.

• Non Operating Income for Q4 2023 came in at $6.9 million, down 45.19% year-over-year; the trailing twelve-month figure through Dec 2023 was $2.5 million (down 54.05% YoY), and the FY2025 annual result was -$1.2 million, up 8.23% from the prior year.
• Non Operating Income came in at $6.9 million for Q4 2023 at Scinai Immunotherapeutics, up from -$5.2 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $21.6 million in Q2 2020 to a low of -$6.9 million in Q3 2022.
• The 5-year median for Non Operating Income is -$70000.0 (2022), against an average of $1.8 million.
• Across the five-year window, Non Operating Income tumbled 732.63% in 2021 and jumped 952.0% in 2022, its largest moves.
• Scinai Immunotherapeutics' Non Operating Income stood at -$618000.0 in 2019, then jumped by 34.14% to -$407000.0 in 2020, then surged by 394.84% to $1.2 million in 2021, then surged by 952.0% to $12.6 million in 2022, then sank by 45.19% to $6.9 million in 2023.
• The last three Non Operating Income figures came in at $6.9 million (Q4 2023), -$5.2 million (Q3 2023), and $1.2 million (Q2 2023), per Business Quant data.